ACCESS Newswire

Corsair to Supply Shell with Plastic Pyrolysis Oil from Finland

Share

Collaboration Aims to Transform Plastic Waste into Sustainable Circular Chemicals for Everyday Use

HELSINKI, FINLAND / ACCESSWIRE / September 6, 2024 / Plastic waste recycling firm Corsair has signed an agreement to supply Shell Chemicals Europe B.V. with pyrolysis oil, a mixed plastic waste feedstock. Under the agreement Corsair, a company that converts daily household plastic waste into oil through pyrolysis, will deliver pyrolysis oil from its plastic waste chemical recycling facility in Jämsä, Finland, for Shell's facility in Moerdijk, The Netherlands.

null

The pyrolysis oil will be used to manufacture circular chemicals, which are typically used in a wide variety of products found in everyday life, such as cleaning products, textiles, and food packaging.

null

Jussi Veikko Saloranta, CEO of Corsair said: "We are very excited about this collaboration with Shell in Europe. Plastic waste is a critical global issue. Each year, hundreds of billions of kilograms of plastic waste are produced worldwide, yet less than 10% is recycled. It is crucial that we develop efficient methods to recycle discarded plastic into new products, similar to the successful recycling practices for metals, glass, and paper. Incinerating plastic or dumping it in landfills is not a viable solution. The sustainable approach is to transform old plastic into new products. This is what the collaboration between Shell and Corsair is all about."

null

Corsair, which started its operations in Thailand in 2020 and has recently expanded into Europe, has a target to expand internationally for a greater positive impact on the environment.

"Shell looks forward to working with Corsair and processing their pyrolysis oil, thereby supplying our customers with more circular chemicals." says Niels Bouwhuis, Chief Marketing Officer for Shell Chemicals. "This is another step in our drive to help the development of a viable plastic circular value chain," adds Thijs Arlman, Head of Plastic Circularity.

About CORSAIR:

Corsair Group is an international, ISCC-certified plastic waste recycling company that turns daily household plastic waste, such as plastic bags, wrapping materials, and packaging products, into pyrolysis oil at its facilities in Finland and Thailand. With its global head office located in Bangkok and its European head office in Amsterdam, Corsair is on a mission to clean our planet from plastic pollution by recycling discarded plastic waste from the environment and landfills into valuable products.

As part of its global development plan, Corsair aims to expand its plastic waste chemical recycling facilities globally, with a focus on Asia, Europe, and North America.

In addition to its industrial operations as a plastic waste recycler, Corsair is also the developer and issuer of the world's leading plastic waste offset program, the CSR Plastic Credit. Through the CSR Plastic Credit, Corsair helps businesses and individuals reduce and remove the impact their plastic waste has on the environment by becoming Certified Plastic Neutral.

For more information, please visit www.corsairgroup.com.

Contact Info
mail: agostino@corsairnow.com
phone: +66 957 613 702

SOURCE: Corsair group



View the original press release on accesswire.com

Corsair group

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference9.1.2026 18:35:00 CET | Press release

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company's Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company's lead asset PRO CAR - 201A, a STEAP1 directed CAR T cell that is currently in the clinic as a first-in-human phase 1 trial for the treatment of metastatic castration-resistant prostate cancer (mCRPC), at Biotech Showcase 2026 in San Francisco, California on Monday, January 12, 2025 at 11:15 am PST at the Franciscan D (Ballroom Level). About PromiCell, Inc. PromiCell, is a clinical-stage cellular immunotherapy company with product candidates representing highly differentiated and novel CAR T and TCR T platforms to be developed across separate solid and hematologic types of cancer. Our pipeline of innovative products includes STEAP 1 CAR T cells, HA-1 T

Datavault AI Expands IBM Collaboration to Deploy Enterprise-Grade AI at the Edge with Available Infrastructure's SanQtum AI Platform8.1.2026 13:00:00 CET | Press release

Datavault AI will activate a secured multi-city edge AI network for real-time data tokenization, security, and monetization across New York and Philadelphia NEW YORK, NY / ACCESS Newswire / January 8, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in instant data monetization & enterprise digital twins, announced it will deliver enterprise-grade AI performance at the edge in New York and Philadelphia through an expanded collaboration with IBM using the SanQtum AI platform. Operated by Available Infrastructure, SanQtum AI is a fleet of synchronized micro edge data centers running IBM's watsonx portfolio of AI products on a zero-trust network. The combined deployment is designed to enable cybersecure data storage and compute, real-time data scoring, tokenization, and ultra-low-latency, across two of the most data-dense metro regions in the United States. By running Datavault AI's Information Data Exchange and DataScore agents - built with watsonx - within SanQtum AI's zero-trust edge e

Ascend Advanced Therapies - ABL Inc. Further Strengthens Executive Team as It Drives Forward an Ambitious Growth Strategy8.1.2026 13:00:00 CET | Press release

Seiga Ohmine to join as Chief Commercial Officer, Sharad Dubey as Chief Financial Officer and Patrick Lansky as Senior Vice President of Global Business Development Appointments underscore Ascend-ABL's commitment to scientific rigor, operational excellence, and strategic growth ROCKVILLE, MARYLAND / ACCESS Newswire / January 8, 2026 / Ascend Advanced Therapies - ABL Inc. today announced significant appointments to its leadership team. Seiga Ohmine Ph.D. joins as Chief Commercial Officer (CCO) Sharad Dubey CA, CPA joins as Chief Financial Officer (CFO) Patrick Lansky joins as Senior Vice President of Global Business Development These appointments reflect Ascend-ABL's focus on strengthening scientific leadership, operational discipline, and customer-centric execution as the company sharpens its positioning as a trusted CDMO partner for advanced viral modalities. Commenting on the appointments, Alessandra Rispoli, Chief Executive Officer of Ascend-ABL said, "We are making strong progress

Market Logic Announces Technology Partnership with Zappi to Accelerate Innovation with AI8.1.2026 08:00:00 CET | Press release

BERLIN, DE / ACCESS Newswire / January 8, 2026 / Market Logic Software is excited to announce a technology partnership with Zappi designed to help leading brands develop, refine, and test new product concepts faster than ever before. United by a joint agentic AI framework, this collaboration brings together advanced AI capabilities from both companies, marking a pivotal shift in how organizations execute insights-driven innovation. Through AI-to-AI integrations, linking two powerful AI platforms, enterprises can now enrich their product innovation process with a comprehensive data ecosystem. Specially trained DeepSights AI agents within Market Logic's Innovation Studio continuously monitor, analyse, and synthesize market research, news, and operational data-allowing for accelerated concept generation and more informed decision-making. With just a couple of clicks, customers can seamlessly progress to testing their concepts with real people, thanks to Zappi's real-world respondent solut

RE Royalties Announces up to a USD $9.0 Million Portfolio-Level Royalty Investment with Solaris Energy Inc.7.1.2026 22:20:00 CET | Press release

VANCOUVER, BC / ACCESS Newswire / January 7, 2026 / RE Royalties Ltd. (TSXV:RE)(OTCQX:RROYF) ("RE Royalties" or the "Company") is pleased to announce that it has entered into a definitive agreement with Solaris Energy Inc. ("Solaris") to invest up to USD $9.0 million to acquire a royalty interest (the "Royalty Purchase") in two portfolios of distributed generation ("DG") solar projects located throughout the United States. The first portfolio consists of 15 projects including 9 under construction with several nearing operation, and 6 in development, located across California, Maine, Delaware, New Hampshire and Colorado ("Portfolio 1"). The second portfolio comprises 9 more projects, the final composition of which may evolve as the projects advance ("Portfolio 2"). The transaction represents the acquisition of a portfolio level royalty on a diversified portfolio of DG solar assets and marks the exciting beginning of a new partnership between the two parties. The Royalty Purchase for Por

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye